These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8407594)

  • 1. Angelmicins, new inhibitors of oncogenic src signal transduction.
    Uehara Y; Li PM; Fukazawa H; Mizuno S; Nihei Y; Nishio M; Hanada M; Yamamoto C; Furumai T; Oki T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1306-8. PubMed ID: 8407594
    [No Abstract]   [Full Text] [Related]  

  • 2. Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
    Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y
    Leuk Res; 1996 Jun; 20(6):491-7. PubMed ID: 8709621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
    Uehara Y; Fukazawa H
    Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protein kinase inhibitors--screening of new molecular target therapeutics].
    Uehara Y
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):136-44. PubMed ID: 9030224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCS15A, a non-kinase inhibitor of Src signal transduction.
    Sharma SV; Oneyama C; Yamashita Y; Nakano H; Sugawara K; Hamada M; Kosaka N; Tamaoki T
    Oncogene; 2001 Apr; 20(17):2068-79. PubMed ID: 11360191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.
    Whitesell L; Mimnaugh EG; De Costa B; Myers CE; Neckers LM
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8324-8. PubMed ID: 8078881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene signal transduction inhibitors from medicinal plants.
    Chang CJ; Ashendel CL; Geahlen RL; McLaughlin JL; Waters DJ
    In Vivo; 1996; 10(2):185-90. PubMed ID: 8744799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic principles of signal transduction].
    Yarden Y
    Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of Stat3 by v-Src is through a Ras-independent pathway.
    Liu JJ; Nakajima K; Hirano T; Yang-Yen HF
    J Biomed Sci; 1998; 5(6):446-50. PubMed ID: 9845849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase inhibitors: novel tools in cancer therapy.
    Marmé D
    Urologe A; 2004 Sep; 43 Suppl 3():S148. PubMed ID: 15148578
    [No Abstract]   [Full Text] [Related]  

  • 11. SH2 mutants of c-src that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated c-src.
    Hirai H; Varmus HE
    Genes Dev; 1990 Dec; 4(12B):2342-52. PubMed ID: 1703982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.
    Whitesell L; Shifrin SD; Schwab G; Neckers LM
    Cancer Res; 1992 Apr; 52(7):1721-8. PubMed ID: 1551101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells.
    Imoto M; Taniguchi Y; Fujiwara H; Umezawa K
    Exp Cell Res; 1994 May; 212(1):151-4. PubMed ID: 7909754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v-Src-induced transformation is inhibited by okadaic acid.
    Gupta RW; Joseph CK; Foster DA
    Biochem Biophys Res Commun; 1993 Oct; 196(1):320-7. PubMed ID: 8216307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways.
    Gala M; Sun R; Yang VW
    Cancer Lett; 2002 Jan; 175(1):89-94. PubMed ID: 11734340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein tyrosine kinase inhibitor, herbimycin A].
    Uehara Y; Fukazawa H
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1950-9. PubMed ID: 8210436
    [No Abstract]   [Full Text] [Related]  

  • 17. v-Src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts.
    Qureshi SA; Joseph CK; Rim M; Maroney A; Foster DA
    Oncogene; 1991 Jun; 6(6):995-9. PubMed ID: 2067850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src.
    Akiho H; Tokumitsu Y; Noda M; Nomura Y
    Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
    Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
    Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. I. Taxonomy of the producing organism, fermentation and biological activity.
    Karwowski JP; Jackson M; Sunga G; Sheldon P; Poddig JB; Kohl WL; Kadam S
    J Antibiot (Tokyo); 1994 Aug; 47(8):862-9. PubMed ID: 7928671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.